Recombinant celo virus and celo virus DNA
AssigneeBoehringer Ingelheim International GmbH
InventorsMatthew Cotten, Anne-Isabelle Michou, Gerhard Christofori, Amelia Compagni
Life of this patent
Estimating the term…
Abstract
Recombinant CELO virus or CELO virus DNA with a deletion at the right end of the viral genome that allows insertion of large pieces of foreign DNA. The virus is useful as a vaccine for animals, in particular birds, and for gene therapy and vaccine applications in humans. The virus can also be used for recombinant protein production.
Claims56
Recombinant fowl adenovirus type 1 (CELO) virus or CELO virus DNA, characterized in that the genome contains a deletion consisting essentially of nucleotides 41,731-43,684 of the wild type CELO virus genome.
Recombinant fowl adenovirus type 1 (CELO) virus or CELO virus DNA, characterized in that the genome contains a deletion consisting essentially of nucleotides 41,523-43,684 of the wild type CELO virus genome.
Recombinant fowl adenovirus type 1 (CELO) virus or CELO virus DNA, characterized in that the genome contains a deletion consisting essentially of nucleotides 41,002-43,684 of the wild type CELO virus genome.
Recombinant fowl adenovirus type 1 (CELO) virus or CELO virus DNA, characterized in that the genome contains a deletion consisting essentially of nucleotides 40,065-43,684 of the wild type CELO virus genome.
Dependencies are inferred from the claim text.